Cancer diagnostic and predictive biomarkers

Affiliations

¹ Department of Experimental Oncology, Istituto Nazionale Tumori IRCCS Fondazione Pascale, 80131 Napoli, Italy.
² Department of Microbiology and Immunology, Institute of Human Virology, Baltimore, MD 21201, USA.
³ Department of Research, International Prevention Research Institute, 69006 Lyon, France.
⁴ Department of Pathology, Istituto Nazionale Tumori IRCCS Fondazione Pascale, 80131 Napoli, Italy.
⁵ Department of Research, Sidra Medical and Research Center, 00974 Doha, Qatar.

Editorial

Franco M Buonaguro et al. Biomed Res Int. 2014.

. 2014:2014:980163.

doi: 10.1155/2014/980163. Epub 2014 Apr 3.

¹ Department of Experimental Oncology, Istituto Nazionale Tumori IRCCS Fondazione Pascale, 80131 Napoli, Italy.
² Department of Microbiology and Immunology, Institute of Human Virology, Baltimore, MD 21201, USA.
³ Department of Research, International Prevention Research Institute, 69006 Lyon, France.
⁴ Department of Pathology, Istituto Nazionale Tumori IRCCS Fondazione Pascale, 80131 Napoli, Italy.
⁵ Department of Research, Sidra Medical and Research Center, 00974 Doha, Qatar.

No abstract available

References

1. Srinivas PR, Kramer BS, Srivastava S. Trends in biomarker research for cancer detection. The Lancet Oncology. 2001;2(11):698–704. - PubMed
1. Tornesello ML, Buonaguro L, Tatangelo F, Botti G, Izzo F, Buonaguro FM. Mutations in TP53, CTNNB1 and PIK3CA genes in hepatocellular carcinoma associated with hepatitis B and hepatitis C virus infections. Genomics. 2013;102(2):74–83. - PubMed
1. de Giorgi V, Buonaguro L, Worschech A, et al. Molecular signatures associated with HCV-induced hepatocellular carcinoma and liver metastasis. PLoS ONE. 2013;8(2)e56153 - PMC - PubMed